US Broker Ratings

Medpace Holdings, Inc. (MEDP) Stock Analysis: Growth Potential and Strategic Insights Amid Market Fluctuations

Medpace Holdings, Inc. (NASDAQ: MEDP) has positioned itself as a formidable player within the Healthcare sector, specifically in the Diagnostics & Research industry. The company’s expansive..

AptarGroup, Inc. (ATR) Stock Analysis: Evaluating a 34.96% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) is a formidable player in the medical instruments and supplies industry, operating primarily within the healthcare sector. With its headquarters in Crystal..

Halozyme Therapeutics (HALO) Stock Analysis: Exploring a Promising 33.78% Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is catching the eye of investors with a robust upside potential of 33.78%, according to recent analyst ratings. Specializing in biotechnology,..

Encompass Health Corporation (EHC) Stock Analysis: Unpacking a 32.55% Potential Upside

Investors in Encompass Health Corporation (NYSE: EHC) might find themselves at an intriguing crossroads as they consider the potential trajectory of this healthcare giant. Specializing in..

Waters Corporation (WAT) Investor Outlook: Navigating a 11.88% Potential Upside in the Diagnostics & Research Space

Waters Corporation (NYSE: WAT), a pivotal player in the healthcare sector, specifically within the diagnostics and research industry, offers intriguing prospects for individual investors. With a..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a Potential 38.98% Upside for Savvy Investors

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, prominently situated in the diagnostics and research industry. With a market capitalization..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 29.52% Potential Upside Amidst Market Volatility

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the healthcare sector’s biotechnology industry, offers a compelling investment opportunity with a potential upside of 29.52%. With a..

Exact Sciences Corporation (EXAS): Investor Outlook on This Healthcare Innovator’s 23.1% Revenue Growth

Exact Sciences Corporation (NASDAQ: EXAS), a leader in the healthcare sector, is gaining traction among investors for its innovative contributions to cancer diagnostics and research. Headquartered..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 31.77% Upside Potential Powers Investor Optimism

For investors keen on the biotechnology sector, BeOne Medicines Ltd. (ONC) represents a compelling opportunity with significant upside potential. Based in Basel, Switzerland, this oncology-focused biotech..

DexCom, Inc. (DXCM) Stock Analysis: 37.83% Potential Upside Captivates Investors

DexCom, Inc. (DXCM) stands as a prominent player in the healthcare sector, specializing in the innovative realm of medical devices. This San Diego-based company has carved..

Corcept Therapeutics (CORT) Stock Analysis: Unveiling a 40% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT), a leading biopharmaceutical company, is capturing the attention of investors with its significant potential upside. With a market capitalization of $5.61..

Cencora, Inc. (COR) Stock Analysis: A 36.74% Potential Upside in the Healthcare Sector

Cencora, Inc. (COR), with a robust market capitalization of $50.8 billion, stands as a formidable player in the healthcare sector, specifically in medical distribution. This Conshohocken,..

Solventum Corporation (SOLV) Stock Analysis: Strong ROE and 10.5% Upside Potential Drive Investor Interest

Solventum Corporation (NASDAQ: SOLV), a burgeoning player in the healthcare sector, offers a unique investment opportunity characterized by its diverse portfolio and robust financial metrics. With..

Waystar Holding Corp. (WAY) Investor Outlook: A Potential 62% Upside Amid Robust Revenue Growth

Waystar Holding Corp. (NASDAQ: WAY) is capturing investor attention with its impressive potential upside of 62.48%, based on its average target price of $34.74. As a..

Zoetis Inc. (ZTS) Stock Analysis: An Impressive 64.26% Potential Upside Catches Investor Attention

Zoetis Inc. (NYSE: ZTS), a leading player in the animal health industry, has captured investor interest with its substantial potential upside of 64.26%. As a premier..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 23.15% Potential Upside for Investors

Henry Schein, Inc. (NASDAQ: HSIC) stands as a prominent player in the healthcare sector, specifically within the medical distribution industry. With a substantial market capitalization of..

McKesson Corporation (MCK) Stock Analysis: Analyst Ratings Signal 30% Upside Potential for Healthcare Giant

For investors looking to strengthen their portfolios with a robust player in the healthcare sector, McKesson Corporation (NYSE: MCK) presents a compelling opportunity. With its extensive..

ResMed Inc. (RMD) Stock Analysis: A Leading Healthcare Player with 30% Upside Potential

ResMed Inc. (NYSE: RMD), a prominent figure in the healthcare sector, continues to cement its position as a key player in the medical instruments and supplies..

Chemed Corp (CHE) Stock Analysis: Navigating the Healthcare Sector with a 5.24% Potential Upside

Chemed Corporation (NYSE: CHE), a key player in the healthcare sector, operates on two fronts through its VITAS and Roto-Rooter segments. While VITAS provides essential hospice..

Align Technology, Inc. (ALGN) Stock Analysis: Unlocking 23.87% Potential Upside with a Strong Buy Consensus

Align Technology, Inc. (NASDAQ: ALGN) stands out in the healthcare sector as a key player in the medical instruments and supplies industry. Known for its innovative..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds